Tetragon Partners GP Ltd
Position in AMLX — Amylyx Pharmaceuticals, Inc.
CIK 1515070
GRAND CAYMAN, E9
Position in AMLX
as of Mar 31, 2026
· filed May 15, 2026
Position Value
$4,418,490
+$1,122,728 QoQ
Shares Held
317,877
+16.5% QoQ
Ownership
0.286%
of shares outstanding
% of Portfolio
0.87%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Jun 2025
4 quarters on record
Voting authority
Sole 0.ToString("F0")%
Shared 100.ToString("F0")%
None 0.ToString("F0")%
Common Shares in AMLX Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - Specialty & Generic
Healthcare · as of Mar 31, 2026Tetragon Partners GP Ltd holds $10,068,699 across 2 Drug Manufacturers - Specialty & Generic names. AMLX ranks #2 (43.9% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ALKS |
Alkermes plc.
|
159,791 | $5,650,209 | |
| 2 | AMLX |
Amylyx Pharmaceuticals, Inc.
This page
|
317,877 | $4,418,490 |
All Filings in AMLX
Export CSV
4 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $4,418,490 | 317,877 | Shares | Defined | 2026-05-15 | |
| 2025-12-31 | $3,295,762 | 272,828 | Shares | Defined | 2026-02-17 | |
| 2025-09-30 | $3,509,508 | 258,242 | Shares | Defined | 2025-11-14 | |
| 2025-06-30 | $1,402,187 | 218,750 | Shares | Defined | 2025-08-14 | |
| No filing history on record for this holder in this stock. | ||||||